Top 10 Companies in the NMN Raw Materials Market (2026): Market Leaders Driving Global Longevity Innovation

MARKET INSIGHTS

Global NMN raw materials market size was valued at USD 179 million in 2025 and is projected to reach USD 523 million by 2034, exhibiting a CAGR of 12.6% during the forecast period from 2026 to 2034.

Nicotinamide Mononucleotide (NMN) is a vital nucleotide derived from ribose and nicotinamide. It serves as a direct precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for fundamental biological processes including cellular energy metabolism, DNA repair, and activation of sirtuins, which are proteins linked to longevity. The raw material is the foundational, bulk ingredient used by manufacturers in the nutraceutical, cosmetic, and pharmaceutical industries.

The market growth is primarily propelled by the escalating global demand for anti‑aging and longevity supplements, fueled by growing consumer health consciousness and an aging population. Significant investments in research validating NMN’s role in cellular health are further accelerating adoption. While China dominates the global production landscape, North America represents the largest consumption market. Key manufacturers are increasingly focusing on enzymatic synthesis methods to produce high‑purity NMN that meets stringent quality standards for end‑use applications.

NMN Raw Materials Market – View in Detailed Research Report

1. Bontac Bio‑Engineering (Shenzhen) Co., Ltd.

   Headquarters: Shenzhen, China

   Key Offering: Pharmaceutical‑grade NMN produced via proprietary enzymatic synthesis, achieving purity >99%.

   Bontac has positioned itself at the forefront of the NMN supply chain by investing heavily in biocatalytic platforms that reduce process time and lower heavy‑metal contamination. The company’s cGMP‑certified facilities enable it to supply both the nutraceutical and emerging pharmaceutical sectors with consistent, traceable raw material.

   Sustainability & Growth Initiatives:

   • Adoption of green chemistry principles in fermentation processes.
   • Strategic partnerships with global nutraceutical firms to secure long‑term supply contracts.
   • Continuous improvement of downstream purification to maintain >99% purity.

2. Yuyao Lifespan Health Technology Co., Ltd.

   Headquarters: Yuyao, China

   Key Offering: High‑purity NMN and related NAD+ precursors produced through large‑scale fermentation.

   Yuyao Lifespan has expanded its production capacity by 40% in recent years, positioning it to meet surging demand across Asia‑Pacific and North America. Its integrated supply chain allows for rapid scaling of raw material to support both supplement and pharmaceutical clients.

   Sustainability & Growth Initiatives:

   • Vertical integration of upstream and downstream operations to reduce waste.
   • Investment in energy‑efficient bioreactors.
   • Collaboration with academic institutions on formulation research.

3. Anhui GSH Bio‑Technology Co., Ltd.

   Headquarters: Hefei, China

   Key Offering: Enzymatic synthesis of NMN and NR with cGMP compliance.

   With a strong track record in NAD+ precursor manufacturing, Anhui GSH supplies both domestic and international nutraceutical brands. Its focus on rigorous quality control ensures that its raw material meets the highest safety and purity benchmarks.

   Sustainability & Growth Initiatives:

   • Implementation of closed‑loop water recycling in production.
   • Participation in industry consortia to set global purity standards.
   • Development of scalable micro‑fermentation processes.

4. Kingdomway Group

   Headquarters: Beijing, China

   Key Offering: NMN integrated into a broader portfolio of vitamins and coenzymes, distributed through North American channels.

   Kingdomway leverages its public listing and existing distribution network to expand NMN reach into the U.S. market, offering a reliable source for premium supplement manufacturers.

   Sustainability & Growth Initiatives:

   • Expansion of North American distribution infrastructure.
   • Commitment to ISO 9001 quality management.
   • Investment in low‑carbon logistics solutions.

5. EffePharm Co., Ltd.

   Headquarters: Shanghai, China

   Key Offering: Patented purification processes that enhance bioavailability of NMN.

   EffePharm’s focus on advanced purification has positioned it as a preferred supplier for formulators seeking high‑performance ingredients. The company’s technology reduces endotoxin levels, a critical parameter for pharmaceutical‑grade products.

   Sustainability & Growth Initiatives:

   • Research into biodegradable packaging for bulk shipments.
   • Partnerships with green chemistry startups.
   • Continuous improvement of analytical validation protocols.

6. Shenzhen Herbasource Biotechnology Co., Ltd.

   Headquarters: Shenzhen, China

   Key Offering: GMP‑certified NMN for export to Europe and North America.

   Herbasource’s GMP certification and traceability features make it a trusted partner for companies that must demonstrate compliance with stringent regulatory frameworks.

   Sustainability & Growth Initiatives:

   • Implementation of renewable energy in manufacturing facilities.
   • Collaboration with EU regulatory bodies to streamline approval pathways.
   • Adoption of digital traceability platforms.

7. Jiangxi Haiwen Biotechnology Co., Ltd.

   Headquarters: Nanchang, China

   Key Offering: Fermentation‑based NMN with scalable production lines.

   Jiangxi Haiwen has built a reputation for consistent quality and cost‑effective production, serving both domestic and export markets.

   Sustainability & Growth Initiatives:

   • Optimization of raw‑material sourcing to reduce carbon footprint.
   • Investment in modular bioreactor units for rapid capacity expansion.
   • Engagement in joint ventures with specialty nutraceutical firms.

8. RubyBerries Inc.

   Headquarters: Austin, Texas, USA

   Key Offering: Certified, traceable NMN tailored for North American nutraceuticals.

   RubyBerries provides a domestic alternative to Chinese‑sourced material, mitigating regulatory uncertainty and supply‑chain risk for U.S. buyers.

   Sustainability & Growth Initiatives:

   • Compliance with FDA dietary supplement regulations.
   • Partnerships with local ingredient suppliers to reduce shipping emissions.
   • Investment in digital quality‑control dashboards.

9. Harbin Fuerjia Technology Co., Ltd.

   Headquarters: Harbin, China

   Key Offering: High‑purity NMN with European distribution infrastructure.

   Harbin Fuerjia has expanded its footprint into the EU, offering a reliable source for manufacturers navigating post‑Brexit import dynamics.

   Sustainability & Growth Initiatives:

   • Development of low‑emission logistics networks.
   • Integration of blockchain for supply‑chain transparency.
   • Collaboration with EU research institutes on formulation studies.

10. Shenzhen Herbasource Biotechnology Co., Ltd. (Herboveda)

    Headquarters: Shenzhen, China

    Key Offering: GMP‑certified NMN with a focus on high‑purity, low‑endotoxin production.

    Herboveda’s dual branding strategy targets both the European and North American markets, providing a consistent, compliant raw material stream for premium formulations.

    Sustainability & Growth Initiatives:

    • Adoption of renewable energy sources in manufacturing.
    • Implementation of closed‑loop water usage.
    • Investment in AI‑driven process optimization.

NMN Raw Materials Market – View in Detailed Research Report

NMN Raw Materials Market – View in Detailed Research Report

Outlook: The Future of NMN Raw Materials

As the demand for scientifically validated anti‑aging ingredients continues to rise, manufacturers that can deliver pharmaceutical‑grade purity at scale will capture the largest share of the market. The convergence of clinical research, regulatory clarity in North America, and the expansion of high‑purity production in Japan and China will shape supply dynamics. Companies that embed sustainability into their production and logistics will gain a competitive edge, particularly as consumers and regulators increasingly scrutinize environmental impact.

Future Trends

• Accelerated development of liposomal and sublingual delivery systems that increase bioavailability.
• Expansion of NMN derivatives and combination therapies targeting metabolic and neuro‑degenerative pathways.
• Growth of digital traceability and blockchain solutions to satisfy regulatory and consumer demand for transparency.
• Integration of AI‑driven process optimization to reduce production costs and improve yield.
• Emergence of regional manufacturing hubs in Southeast Asia to diversify supply chains.